Article ID: CBB378275066

“It Works! Now What?” Insulin Development, Production, and Distribution at Connaught Laboratories, University of Toronto, 1922–24 (2022)

unapi

The first successful human use of a pancreatic extract on Leonard Thompson, a 13-year-old severe diabetic at Toronto General Hospital, on 23 January 1922, is generally seen as the climax of the discovery-of-insulin story. However, this seminal event in the history of medicine begs the question: “It works! Now what?” The story may well have ended abruptly if not for the foresight and leadership of Dr. John G. FitzGerald, director of the University of Toronto’s Connaught Antitoxin Laboratories, based in the basement of the same Medical Building where F.G. Banting and C.H. Best, under the direction of J.J.R. Macleod, conducted the research that led to the first tests on Thompson. Significantly, it was the addition to the team of biochemist J.B. Collip and his purification of the extract that enabled the successful 23 January test. Within a day, however, tensions within the group, especially between Banting and Collip, and Collip’s threat to leave and take out his own patent, prompted FitzGerald to act. On 25 January, FitzGerald finalized a seminal agreement between Connaught and Banting, Best, Collip, and Macleod that secured the further development of methods to prepare the extract on a larger scale to enable further clinical testing. From this point, Connaught would play a fundamental role in the insulin story, although its historical significance has been minimized and often misunderstood, overshadowed by the weight of the primary discovery, as well as by the critical contributions of Eli Lilly and Co. This article focuses on Connaught’s intimate involvement in the history of insulin from January 1922 through the summer of 1924, tracing the challenges and innovations of developing larger-scale production methods, the establishment and expansion of Canadian insulin production capacity, and the key role the labs played in spearheading the global distribution of insulin.

...More
Citation URI
https://data.isiscb.org/isis/citation/CBB378275066/

Similar Citations

Article Sinding, Christiane; (2002)
Making the Unit of Insulin: Standards, Clinical Work, and Industry, 1920--1925 (/isis/citation/CBB000201126/)

Article Jurdjevic, Mark; Tillman, Caitlin; (2004)
E. C. Noble in June 1921, and His Account of the Discovery of Insulin (/isis/citation/CBB000630238/)

Article Cassier, Maurice; Sinding, Christiane; (2008)
“Patenting in the Public Interest”: Administration of Insulin Patents by the University of Toronto (/isis/citation/CBB000850054/)

Book Kathryn T. Hall; (2022)
Placebos (/isis/citation/CBB774087923/)

Article Miller, Franklin G.; (2012)
Homage to Henry Beecher (1904--1976) (/isis/citation/CBB001201290/)

Article Klingle, Matthew W.; (April 2018)
The Multiple Lives of Marjorie: The Dogs of Toronto and the Co-discovery of Insulin (/isis/citation/CBB038551290/)

Book Tattersall, Robert; (2009)
Diabetes: The Biography (/isis/citation/CBB001021106/)

Article Richard M. Mizelle; (2020)
Hurricane Katrina, Diabetes, and the Meaning of Resiliency (/isis/citation/CBB673575822/)

Chapter Sinding, Christiane; (2005)
Les multiples usages de la quantification en médicine: Le cas du diabète sucré (/isis/citation/CBB000772033/)

Book Best, Henry B. M.; (2003)
Margaret and Charley: The Personal Story of Dr. Charles Best, The Co-Discoverer of Insulin (/isis/citation/CBB000650893/)

Book Feudtner, Christ; (2003)
Bittersweet: Diabetes, Insulin, and the Transformation of Illness (/isis/citation/CBB000320299/)

Article Dunaway, Finis; (April 2018)
Gallery Editor's Note (/isis/citation/CBB820380875/)

Article Aaron T. Norton; (October 2017)
Foreskin and the molecular politics of risk (/isis/citation/CBB510383345/)

Article Franklin G. Miller; (2020)
Revisiting the Distinction and the Connection Between Research and Practice (/isis/citation/CBB749659220/)

Authors & Contributors
Sinding, Christiane
Miller, Franklin G.
Kais Elleuche
Skander Elleuche
Kathryn T. Hall
John P.M. Court
Concepts
Insulin
Diabetes
Medical research
Pharmaceutical industry
Clinical medicine
Clinical trials
Time Periods
20th century, early
20th century
20th century, late
19th century
21st century
Places
Canada
United States
Gulf of Mexico
New Orleans (Louisiana, U.S.)
East Germany
Great Britain
Institutions
University of Toronto
Eli Lilly and Company
Comments

Be the first to comment!

{{ comment.created_by.username }} on {{ comment.created_on | date:'medium' }}

Log in or register to comment